Strides Pharma Science informs about press release

18 Jan 2023 Evaluate
Strides Pharma Science has informed that it attached Press Release issued by the Company titled ‘Stelis Biopharma’s flagship facility receives EIR from the USFDA on the successful closure of its inspection specific to Drug-Device Combination Products’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

904.80 7.45 (0.83%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×